NRI Pulse
Business

Ranbaxy to pay $40 mn to settle Texas litigation

New Delhi, Oct 16 (IANS) Drugmaker Ranbaxy Laboratories Thursday said it has settled the litigation concerning its participation in the Texas Medicaid Program and agreed to pay $39.75 million.

The company has informed this to the Bombay Stock Exchange (BSE) in a filing.

It said: “Ranbaxy has settled the litigation concerning its participation in the Texas Medicaid Program. Under the settlement agreement, Ranbaxy will make payments to the State of Texas totalling $39.75 million in a series of tranches through August 2015.”

The company is in the process of being acquired by larger rival Sun Pharmaceutical Industries Ltd.

Ranbaxy shares traded at Rs.589.85 per share, down 1.37 percent, at the BSE during the closing at 4 p.m. Thursday.

Related posts

Murthy gets investors' nod to steer Infosys, warns of tough decisions

Veena

JAG’S THOUGHTS: What can businesses do to combat the coronavirus?

Veena

Twitter hires Rinki Sethi as new information security head

Veena

Leave a Comment